FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application from Sandoz Inc. for Leuprolide acetate (ANDA 074728).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)

Snippet

SUPPL AP for LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)